Additional file 2: of Nilotinib (Tasignaâ˘) in the treatment of early diffuse systemic sclerosis: an open-label, pilot clinical trial
Jessica Gordon
Viktor Martyanov
Cynthia Magro
Horatio Wildman
Tammara Wood
Wei-Ti Huang
Mary Crow
Michael Whitfield
Robert Spiera
10.6084/m9.figshare.c.3636080_D5.v1
https://springernature.figshare.com/articles/journal_contribution/Additional_file_2_of_Nilotinib_Tasigna_in_the_treatment_of_early_diffuse_systemic_sclerosis_an_open-label_pilot_clinical_trial/4440452
Dermatopathology results. ÎąSMA alpha smooth muscle actin, Egr early growth response protein. (DOCX 15 kb)
2015-08-18 05:00:00
muscle actin
Additional
trial Dermatopathology results
growth response protein
Nilotinib
open-label
DOCX 15 kb
Egr
Îą SMA
Tasigna
sclerosis